logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Annika Auranen

Tampere University Hospital
H指数:34
被引数:7,240

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Implementation of extensive cytoreductive surgery protocol in advanced epithelial ovarian cancer: Real-world data on surgical treatment distribution and survival of the whole patient cohort; a single center experience

实施广泛细胞减灭术方案在晚期上皮性卵巢癌中的应用：全患者队列的手术治疗分布与生存情况的现实世界数据；一项单中心经验

Acta Obstetricia et Gynecologica Scandinavica
IF3.1
2025-07-180
OAAI
Niina Norppa; Synnöve Staff; Mika Helminen; Annika Auranen; Sami Saarelainen
NSGO-FANDANGO/ENGOT-EN1: A randomized phase II study of first-line combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancer

NSGO-FANDANGO/ENGOT-EN1：一项关于在晚期/复发性子宫内膜癌中使用尼达尼布/安慰剂联合一线化疗的随机Ⅱ期研究

gynecologic oncology
IF4.1
2025-06-300
PRE
Kristina Lindemann; Dominique Berton; Jalid Sehouli; René DePont Christensen; Sevilay Altintas; Anja Ør Knudsen; Pierre-Etienne Heudel; Beyhan Ataseven; Ignace Vergote; Gabriel Lindahl; Coriolan Lebreton; Fabienne Schochter; Annika Auranen; Philippe Follana; Kristine Madsen; Frédéric Selle; Karen Stampe Petersson; Florence Joly; Elena Ioana Braicu; Mansoor Raza Mirza
Palbociclib plus letrozole in estrogen receptor-positive advanced/ recurrent endometrial cancer: Double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trial

帕博西利联合来曲唑在雌激素受体阳性晚期/复发性子宫内膜癌中的应用：双盲安慰剂对照随机II期ENGOT-EN3/PALEO试验

gynecologic oncology
IF4.1
2025-01-011
OAAI
Mirza, Mansoor R.; Bjorge, Line; Marme, Frederik; Christense, Rene DePont; Gil-Martin, Marta; Auranen, Annika; Ataseven, Beyhan; Rubio, Maria Jesus; Salutari, Vanda; Luczak, Adam A.; Runnebaum, Ingo B.; Redondo, Andres; Lindemann, Kristina; Trillsc, Fabian; Ginesta, M. Pilar Barretina; Roed, Henrik; Kurtz, Jean-Emmanuel; Petersson, Karen S.; Nyvang, Gitte-Bettina; Sehouli, Jalid
Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2024-09-280
OAAI
Auranen, Annika; Powell, Matthew A.; Sukhin, Vladyslav; Landrum, Lisa M.; Ronzino, Graziana; Buscema, Joseph; Bauerschlag, Dirk; Lalisang, Roy; Bender, David; Gilbert, Lucy; Armstrong, Amy; Safra, Tamar; Nevadunsky, Nicole; Sebastianelli, Alexandra; Slomovitz, Brian; Ring, Kari; Coleman, Robert; Podzielinski, Iwona; Stuckey, Ashley; Teneriello, Michael; Gill, Sarah; Pothuri, Bhavana; Willmott, Lyndsay; Sharma, Sudarshan; Dabrowski, Christine; Antony, Grace; Stevens, Shadi; Mirza, Mansoor Raza; Fleming, Evelyn
Clinical and molecular characteristics of gynecologic cancer patients in FINPROVE: The national phase II drug repurposing trial in Finland

FINPROVE试验中妇科癌患者的临床与分子特征：芬兰国家性二期药物重定位试验

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Farkkila, A.; Suoknuuti, A.; Lassus, H. J.; Tanner, M. M. E.; Alanne, E.; Kaariainen, O-S.; Iivanainen, S. M. E.; Auranen, A.; Simojoki, M. K.; Arola, J.; Pasanen, A.; Niemela, E.; Vainionpaa, R.; Kaikkonen, E.; Virtanen, A.; Kytola, S.; Jalkanen, K.
A Plain Language Summary of Dostarlimab for primary advanced or recurrent endometrial cancer
FUTURE ONCOLOGY
IF2.6
2024-07-010
PRE
Mirza, Mansoor R.; Chase, Dana M.; Slomovitz, Brian M.; Christensen, Rene dePont; Novak, Zoltan; Black, Destin; Gilbert, Lucy; Sharma, Sudarshan; Valabrega, Giorgio; Landrum, Lisa M.; Hanker, Lars C.; Stuckey, Ashley; Boere, Ingrid; Gold, Michael A.; Auranen, Annika; Pothuri, Bhavana; Cibula, David; McCourt, Carolyn; Raspagliesi, Francesco; Shahin, Mark S.; Gill, Sarah E.; Monk, Bradley J.; Buscema, Joseph; Herzog, Thomas J.; Copeland, Larry J.; Tian, Min; He, Zangdong; Stevens, Shadi; Zografos, Eleftherios; Coleman, Robert L.; Powell, Matthew A.
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2023-06-08294
OA
Mirza, M. R.; Chase, D. M.; Slomovitz, B. M.; Christensen, R. Depont; Novak, Z.; Black, D.; Gilbert, L.; Sharma, S.; Valabrega, G.; Landrum, L. M.; Hanker, L. C.; Stuckey, A.; Boere, I.; Gold, M. A.; Auranen, A.; Pothuri, B.; Cibula, D.; McCourt, C.; Raspagliesi, F.; Shahin, M. S.; Gill, S. E.; Monk, B. J.; Buscema, J.; Herzog, T. J.; Copeland, L. J.; Tian, M.; He, Z.; Stevens, S.; Zografos, E.; Coleman, R. L.; Powell, M. A.
Quality-adjusted time without symptoms of disease or toxicity and quality-adjusted progression-free survival with niraparib maintenance in first-line ovarian cancer in the PRIMA trial

PRIMA试验中无疾病或毒性症状的质量调整时间和尼拉帕尼维持治疗一线卵巢癌的质量调整无进展生存期

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2022-09-226
OAAI
Barretina-Ginesta, Maria-Pilar; Monk, Bradley J.; Han, Sileny; Pothuri, Bhavana; Auranen, Annika; Chase, Dana M.; Lorusso, Domenica; Anderson, Charles; Abadie-Lacourtoisie, Sophie; Cloven, Noelle; Braicu, Elena, I; Amit, Amnon; Redondo, Andres; Shah, Ruchit; Kebede, Nehemiah; Hawkes, Carol; Gupta, Divya; Woodward, Tatia; O'Malley, David M.; Gonzalez-Martin, Antonio
Quality-adjusted time without symptom or toxicity (QA-TWiST) and quality-adjusted progression-free survival (QA-PFS) of first-line (1L) maintenance niraparib in patients with advanced ovarian cancer (OC): Results from the PRIMA trial
ANNALS OF ONCOLOGY
IF65.4
2021-09-015
OAAI
Barretina-Ginesta, M-P.; Monk, B. J.; Han, S.; Pothuri, B.; Auranen, A.; Chase, D.; Lorusso, D.; Anderson, C.; Abadie-Lacourtoisie, S.; Cloven, N.; Braicu, E. I.; Amit, A.; Redondo, A.; Shah, R.; Kebede, N.; Hawkes, C.; Gupta, D.; Woodward, T.; O'Malley, D. M.; Gonzalez Martin, A. J.
Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report
GENETICS IN MEDICINE
IF6.2
2021-04-0125
OAAI
Dominguez-Valentin, Mev; Crosbie, Emma J.; Engel, Christoph; Aretz, Stefan; Macrae, Finlay; Winship, Ingrid; Capella, Gabriel; Thomas, Huw; Nakken, Sigve; Hovig, Eivind; Nielsen, Maartje; Sijmons, Rolf H.; Bertario, Lucio; Bonanni, Bernardo; Tibiletti, Maria Grazia; Cavestro, Giulia Martina; Mints, Miriam; Gluck, Nathan; Katz, Lior; Heinimann, Karl; Vaccaro, Carlos A.; Green, Kate; Lalloo, Fiona; Hill, James; Schmiegel, Wolff; Vangala, Deepak; Perne, Claudia; Strauss, Hans-Georg; Tecklenburg, Johanna; Holinski-Feder, Elke; Steinke-Lange, Verena; Mecklin, Jukka-Pekka; Plazzer, John-Paul; Pineda, Marta; Navarro, Matilde; Brunet Vidal, Joan; Kariv, Revital; Rosner, Guy; Alejandra Pinero, Tamara; Laura Gonzalez, Maria; Kalfayan, Pablo; Ryan, Neil; Ten Broeke, Sanne W.; Jenkins, Mark A.; Sunde, Lone; Bernstein, Inge; Burn, John; Greenblatt, Marc; Cappel, Wouter H. de Vos tot Nederveen; Della Valle, Adriana; Lopez-Koestner, Francisco; Alvarez, Karin; Buettner, Reinhard; Goergens, Heike; Morak, Monika; Holzapfel, Stefanie; Hueneburg, Robert; Doeberitz, Magnus von Knebel; Loeffler, Markus; Rahner, Nils; Weitz, Jurgen; Pylvanainen, Kirsi; Renkonen-Sinisalo, Laura; Lepisto, Anna; Auranen, Annika; Hopper, John L.; Win, Aung Ko; Haile, Robert W.; Lindor, Noralane M.; Gallinger, Steven; Le Marchand, Loic; Newcomb, Polly A.; Figueiredo, Jane C.; Thibodeau, Stephen N.; Therkildsen, Christina; Okkels, Henrik; Ketabi, Zohreh; Denton, Oliver G.; Rodland, Einar Andreas; Vasen, Hans; Neffa, Florencia; Esperon, Patricia; Tjandra, Douglas; Moeslein, Gabriela; Sampson, Julian R.; Evans, D. Gareth; Seppala, Toni T.; Moller, Pal
A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER plus ) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial
ANNALS OF ONCOLOGY
IF65.4
2020-09-0149
OAAI
Mirza, M. R.; Bjorge, L.; Marme, F.; Christensen, R. DePont; Gil-Martin, M.; Auranen, A.; Ataseven, B.; Rubio, M. J.; Salutari, V.; Lund, B.; Runnebaum, I.; Redondo, A.; Lindemann, K.; Trillsch, F.; Barretina Ginesta, M. P.; Roed, H.; Lohndorf, J.; Nyvang, G-B.; Sehouli, J.

研究方向

暂未获取到该数据
S
Seija Grénman
H 指数:42论文数:314被引数:7,031
J
Johanna Hynninen
H 指数:27论文数:270被引数:2,990
R
René dePont Christensen
H 指数:33论文数:154被引数:8,882
K
Kaisa Huhtinen
H 指数:30论文数:244被引数:2,921
B
Bhavana Pothuri
H 指数:43论文数:449被引数:9,238
O
Olli Carpén
H 指数:69论文数:459被引数:1.8万
K
Kristina Lindemann
H 指数:33论文数:245被引数:4,575
A
Andrés Redondo
H 指数:45论文数:382被引数:1.4万
D
Dana M. Chase
H 指数:31论文数:269被引数:4,158
S
Sampsa Hautaniemi
H 指数:58论文数:510被引数:1.1万